IBEX Ltd. Announces Board Changes and Executive Compensation Updates

Ticker: IBEX · Form: 8-K · Filed: Oct 29, 2024 · CIK: 1720420

Ibex LTD 8-K Filing Summary
FieldDetail
CompanyIbex LTD (IBEX)
Form Type8-K
Filed DateOct 29, 2024
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.0001, $75,000
Sentimentneutral

Sentiment: neutral

Topics: board-changes, executive-compensation, governance

TL;DR

IBEX Ltd. shakes up its board and adjusts exec pay. New directors in, one out.

AI Summary

On October 24, 2024, IBEX Ltd. filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the company announced the departure of Director Michael J. McNeely and the appointment of new directors, including David L. Johnson and David M. Ruggiero. The filing also outlines updated compensatory arrangements for certain officers.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Board and executive changes can introduce uncertainty regarding future strategy and leadership stability.

Key Players & Entities

FAQ

Who has departed from IBEX Ltd.'s board of directors?

Michael J. McNeely has departed from IBEX Ltd.'s board of directors as of October 24, 2024.

Who are the newly appointed directors at IBEX Ltd.?

David L. Johnson and David M. Ruggiero have been appointed as new directors at IBEX Ltd.

What is the exact date of the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on October 24, 2024.

What specific items are covered in this 8-K filing for IBEX Ltd.?

This 8-K filing covers the departure of directors, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

What is the company's state of incorporation?

IBEX Ltd. is incorporated in Bermuda.

Filing Stats: 852 words · 3 min read · ~3 pages · Grade level 10.9 · Accepted 2024-10-28 19:00:33

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. A copy of the press release announcing the matters described above is attached to this report as Exhibit 99.1 and incorporated herein by reference. The information contained in Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified therein as being incorporated by reference.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. EXHIBIT INDEX Exhibit No. Description 99.1 Press release, dated October 28, 2024 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IBEX LIMITED (Registrant) Date: October 28, 2024 /s/ Robert Dechant (Signature) Name: Robert Dechant Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing